Japanese Journal of Ophthalmology 2004-01-01

Comparison of 0.1% bromfenac sodium and 0.1% pemirolast potassium for the treatment of allergic conjunctivitis.

Minori Miyake-Kashima, Yoji Takano, Mari Tanaka, Yoshiyuki Satake, Tetsuya Kawakita, Murat Dogru, Naoko Asano-Kato, Kazumi Fukagawa, Hiroshi Fujishima

文献索引:Jpn. J. Ophthalmol. 48(6) , 587-90, (2004)

全文:HTML全文

摘要

We compared the efficacy of a new nonsteroidal antiinflammatory drug (NSAID) eye drop, 0.1% bromfenac sodium (Bromfenac), with that of an antiallergic agent, 0.1% pemirolast potassium (Pemirolast), in the treatment of seasonal allergic conjunctivitis in Japanese patients.Twenty-two subjects with seasonal allergic conjunctivitis were enrolled in the study. One eye was treated with Bromfenac eye drops and the contralateral eye was treated with Pemirolast eye drops for 1 week. Subjective ocular symptoms and objective ocular signs evaluated by slit-lamp examination were scored and recorded before and after treatment.Both drugs significantly decreased ocular signs after 1 week, but not symptoms. No significant differences in subjective symptoms or objective signs were observed between the two drugs. Ten patients (45.5%) selected Bromfenac as more effective, nine patients (40.9%) selected Pemirolast, and three patients found no difference in efficacy between the two drugs.Bromfenac sodium is as safe and effective for the treatment of allergic conjunctivitis as pemirolast potassium.


相关化合物

  • 吡嘧司特钾

相关文献:

A combined analysis of two studies assessing the ocular comfort of antiallergy ophthalmic agents.

2003-04-01

[Clin. Ther. 25(4) , 1096-106, (2003)]

Peripheral interstitial keratitis: a novel manifestation of ocular mastocytosis.

2006-04-01

[Cornea 25(3) , 364-7, (2006)]

Two mast cell stabilizers, pemirolast potassium 0.1% and nedocromil sodium 2%, in the treatment of seasonal allergic conjunctivitis: a comparative study.

2003-01-01

[Adv. Ther. 20(1) , 31-40, (2003)]

The effect of a combined therapy with a histamine H1 antagonist and a chemical mediator release inhibitor on allergic conjunctivitis.

2008-01-01

[Ophthalmologica 222(4) , 232-9, (2008)]

New drugs for allergic conjunctivitis.

2000-05-01

[Med. Lett. Drugs Ther. 42(1077) , 39-40, (2000)]

更多文献...